Envoy Medical, Inc. (NASDAQ:COCHW – Get Free Report) saw a large drop in short interest in September. As of September 30th, there was short interest totaling 2,168 shares, a drop of 93.3% from the September 15th total of 32,325 shares. Based on an average daily volume of 24,603 shares, the short-interest ratio is currently 0.1 days.
Envoy Medical Stock Performance
Shares of COCHW remained flat at $0.04 during mid-day trading on Friday. The stock has a 50-day simple moving average of $0.04 and a two-hundred day simple moving average of $0.05. Envoy Medical has a one year low of $0.02 and a one year high of $0.10.
About Envoy Medical
Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technology is designed to be implanted beneath the skin, with the goal of providing hearing support without the external components used by many conventional hearing devices.
Its lead product is the Acclaim cochlear implant, a fully implanted device that uses the body’s natural anatomy to capture sound and stimulate the cochlea. The Acclaim is intended for adults with sensorineural hearing loss and has received Breakthrough Device designation from the U.S.
See Also
- Five stocks we like better than Envoy Medical
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
